Universita' Degli Studi Di Modena E Reggio Emilia — Clinical Trial Site

15 Registered trials

6 Currently recruiting

Organisation

Universita' Degli Studi Di Modena E Reggio Emilia

Location

Modena, Italy

Identifier

ORG-100012284

Address

Via Universita' 4, 41121, Italy

Departments

#2453:S.C. di Pediatria
#8010: S.S. Day Hospital Oncologico
Department of Medical and Surgical Sciences for Children
Dermatology
Dip Scienze Biomediche, Metaboliche e Neuroscienze
Hematology
Infectious Diseases - S.C. di Malattie Infettive
Oncologia medica
S.C. Medicina Interna
SC Ginecologia e Ostetricia
SSD Oncologia
U.O. Malattie Cutanee e Veneree
UOC Ematologia

Clinical trials at this site (15)

Search interface

Clinical study to check the Efficacy and Safety of Mitapivat in Patients with Sickle Cell Disease Pending

2024-515202-84-00 Anemia in subjects with sickle cell disease (SCD) 10
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Part… Recruiting

2025-522151-26-00 Advanced or Metastatic Non-Small-Cell Lung Cancer With 5 2026-02-06
A Phase 3, randomized, open-label, multicenter, controlled study to evaluate the efficacy and safety of zanidatamab in combination with phys… Recruiting

2023-508960-31-00 Metastatic HER2-positive breast cancer 5 2024-12-03
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part… Recruiting

2022-503092-28-00 Relapsed/Refractory Follicular Lymphoma 5 2024-01-08
Long-term safety and tolerability of inclisiran in participants with heterozygous familial hypercholesterolaemia or homozygous familial hype… Recruiting

2023-507278-41-00 Familial hypercholsterolemia 5 2023-02-10
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight … Recruiting

2024-513168-24-00 HIV & Obesity 4 2022-06-01
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
A Clinical Study in which patients with acne vulgaris will receive a new topical drug. The safety and efficacy of the drug will be tested. Ended

2023-510341-19-00 acne vulgaris 5 2024-11-14
A Clinical Study in which patients with acne vulgaris will receive a new topical drug for long term. The safety and efficacy of the drug wil… Ended

2023-510342-24-00 Acne vulgaris 5 2024-11-11
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Ev… Ended

2024-514394-22-00 Actinic Keratosis 6 2022-10-24
Rollover study for continued safety and tolerability in subjects treated with spartalizumab alone or in combination with other study treatme… Ended

2023-508841-42-00 Different types of advanced cancer 3 2019-10-30
A Phase 3 Study of Zanubrutinib (BGB-3111) Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocyt… Ended

2023-509976-40-00 Untreated Chronic Lymphocytic Leukemia or Small Lymphoc 5 2018-05-28
MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of … Ended

2023-506425-12-00 Uncontrolled and Resistant Hypertension 5 2024-04-17
The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 Patients who present late on during their acquisition o 5 2019-08-05